Brooks Laboratories Limited (NSE:BROOKS)
India
· Delayed Price · Currency is INR 137.69
+4.43 (3.32%)
May 16, 2025, 3:27 PM IST
Brooks Laboratories Company Description
Brooks Laboratories Limited manufactures and sells pharmaceuticals in India and internationally.
The company offers liquid and dry powder injection, carbapenem dry powder injectables, tablets, oral suspension, dry syrup, and eye/ear drops.
Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.
Brooks Laboratories Limited
| Country | India |
| Founded | 2002 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 293 |
Contact Details
Address: 201, The Summit Business Bay Mumbai, Maharashtra 400093 India | |
| Phone | 91 22 6907 3100 |
| Website | brookslabs.net |
Stock Details
| Ticker Symbol | BROOKS |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE650L01011 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Prashant Rathi | Chief Financial Officer |
| Dr. Durga Shankar Maity M.Sc. | Whole Time Director |
| Jitendra Pratap Singh | Whole Time Director |
| Bhushan Singh Rana | Whole-Time Director |
| Krutika Mohan Rane | Company Secretary and Compliance Officer |
| Nikhil Anand Verma | Vice President of Sales and Marketing |
| Rajesh Mahajan MBA | President of Procurement |
| Atul Ranchal PGDFMT | President of Corporate Strategy |